Back to search

Article

ImmuniT Platform for Improved Neoantigen Prediction in Lung Cancer

2025-03-18

Abstract excerpt

1 1.1 <h4>Introduction</h4> Lung cancer remains the leading cause of cancer-related deaths, with most patients presenting with advanced, treatment-resistant disease. While immunotherapy has improved outcomes for some, most patients fail to mount an effective immune response due to inadequate tumor recognition. Neoantigen-based therapies offer a promising approach to personalized immunotherapy, but current discove...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
149b5b6d-627c-58ba-809d-3bde042b7be8
DOI
10.1101/2025.03.17.643783
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
ImmuniT Platform for Improved Neoantigen Prediction in Lung CancerDOI 10.1101/2025.03.17.643783
Neoantigen-Based Immunotherapy in Lung Cancer: Advances, Challenges and ProspectsSemantic proximity
Advances and challenges in neoantigen prediction for cancer immunotherapySemantic proximity
A novel integrated approach to predicting cancer immunotherapy efficacySemantic proximity
The role of neoantigens and tumor mutational burden in cancer immunotherapy: advances, mechanisms, and perspectives.Semantic proximity
The Current Lung Cancer Neoantigen Landscape and Implications for Therapy.Semantic proximity
The Role of Neoantigens in Cancer ImmunotherapySemantic proximity
Immunopeptidomics-guided identification of functional neoantigens in non-small cell lung cancerSemantic proximity
Computational methods and data resources for predicting tumor neoantigensSemantic proximity
In silico neoantigen screening and HLA multimer-based validation identify immunogenic neopeptide in multifocal lung adenocarcinoma.Semantic proximity
New emerging targets in cancer immunotherapy: the role of neoantigensSemantic proximity
Integrated modeling to implicate evolving neoantigen-T cell interplays and immunotherapy efficacy in tumorsSemantic proximity
Neoantigens: The Novel Precision Cancer ImmunotherapySemantic proximity
Select a neighboring publication to make it the new centre.